Melphalan Chemoreduction for Ocular Melanoma
Condition(s):Uveal MelanomaLast Updated:June 8, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Uveal MelanomaLast Updated:June 8, 2023Enrolling by invitation
Condition(s):Hearing Loss, Sensorineural; DeafnessLast Updated:March 31, 2020Unknown status
Condition(s):Upper Limb; Injury, Superficial, MultipleLast Updated:December 8, 2021Unknown status
Condition(s):Heart Failure; With Decompensation; Heart Failure,CongestiveLast Updated:October 31, 2018Completed
Condition(s):Peripheral Nerve InjuriesLast Updated:June 21, 2017Completed
Condition(s):InfertilityLast Updated:February 17, 2014Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.